Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
<p>Q2 Holdings' share-price damage feels overstated relative to its fundamentals. The company has moved customers to the cloud, is producing positive free cash flow, and still grows revenue double digits — yet the stock trades nearer its 52-week low than its highs. This trade idea lays out a concrete long entry, stop and target with a clear 180-tra…
Cosmos Health Inc. has repurchased over 5.11 million shares totaling approximately $1.11 million under its ongoing $5 million share repurchase program, demonstrating management's confidence that the stock remains undervalued. The company plans to continue buybacks through the end of 2026, subject to market conditions. Cosmos Health is a diversified…
Malibu Boats, Inc., a leading U.S. manufacturer of recreational powerboats, announced it has been named a finalist in the 2026 Coolest Thing Made in Tennessee contest. The recognition highlights the company's manufacturing innovation and quality, reinforcing its reputation in the boat manufacturing sector. Public voting is open until July 29, 2026.
Micron’s pullback from its 52-week high has created a defined risk / reward for a mid-term swing. Strong profitability, massive free cash flow, and constrained supply for high-bandwidth memory underpin the bullish case, while sector-level volatility and bearish technicals argue for a disciplined entry, tight stop, and realistic target.
nVent Electric plc, a global leader in electrical connection and protection solutions, will release its second quarter 2026 financial results on July 31, 2026. The company will host a conference call and webcast for analysts and investors to discuss the results.
Oracle is navigating near-term margin and license-pressure that keeps the stock under strain. We view the current pullback as a tactical buying opportunity ahead of renewed cloud momentum and AI-driven workloads. Trade plan: enter at $110.00, stop $98.00, target $135.00, horizon 180 trading days.
First Majestic popped after a constructive quarter and two asset sales that de-risk the balance sheet. The company still trades with tight short interest and solid liquidity metrics despite premium valuation metrics. This is a tactical long for a mid-term swing (45 trading days) with defined entry, stop and target.
Micron is the simplest way to play the AI-driven memory cycle without overcomplicating the thesis. The stock has pulled back from its June highs amid sector weakness and macro headlines; fundamentals and cash flow argue for buying this dip with a clearly defined stop and a mid-term target near $1,050.
Adobe is trading at a mid-teens P/E with more than $10 billion in free cash flow, a fortress-like ROE, and visible enterprise demand for content and document AI. Competition is real, but the stock's valuation and strong cash generation make a long trade compelling over the next 180 trading days.
United Fire Group, Inc. will release its second quarter 2026 earnings after market close on August 3, 2026, followed by a management earnings call on August 4, 2026. The company provides property and casualty insurance across all US states and the District of Columbia through independent agencies.
AST SpaceMobile plunged after a $1B convertible-note announcement. I bought a starter position near $60.80 because the selloff appears driven more by dilution fear than changes to the core commercial thesis: direct-to-phone service with carrier partners. With launches in early August and carrier validations in hand, the next 45 trading days offer a…
Roundtable (NASDAQ: RTB), an AI-powered and DeFi-enabled enterprise media platform, announced a comprehensive technology partnership with Mario Nawfal, the world's most-viewed journalist. Under this agreement, Roundtable will provide publishing, monetization, syndication, and business operation infrastructure for Nawfal's owned digital platform, ma…
ImmunityBio (IBRX) is a buy here. The market is discounting ANKTIVA's commercial momentum after an overreaction to promotional conduct headlines earlier this year. With an accepted sBLA, compelling QUILT efficacy numbers, and a PDUFA date of 01/06/2027, the path to re-rating is clear — but not risk-free. Trade plan: enter $7.70, stop $6.50, target …
People Incorporated (PPLI) looks like a classic conglomerate with recognizable consumer-facing assets - digital publishing, home services marketplaces, search and niche staffing platforms. The shares trade at a low price-to-book yet a relatively high price-to-earnings, suggesting the market discounts the asset mix. This trade targets a long-term re…
CO2 Energy Transition Corp. (Nasdaq: NOEM), a special purpose acquisition company focused on energy transition, announced a non-binding Letter of Intent with a Texas-based oil and gas company to recover lithium and strontium from subsurface brines. This strategy seeks to leverage existing oilfield infrastructure to support domestic critical mineral…
Homeland Security Secretary Markwayne Mullin has asked secretaries of state in California, New Jersey, Nevada and Pennsylvania to examine their voter registration lists for possible non-citizen registrants. The request, delivered in letters that cite preliminary reviews of state records, follows a presidential address on election security. The Depa…
QuantumScape (QS) just passed a key operational milestone with pilot Eagle Line production and has fresh automaker validation. The stock trades around $5.78 with a market cap of roughly $3.5B and an attractive technical setup for a tactical swing trade. This idea outlines an entry, stop and target for a mid-term trade while laying out the fundament…
Novo Nordisk has moved from broken market leadership to a credible comeback thanks to a successful oral Wegovy pill launch and improving technicals. At a $225.8B market cap and roughly 12x P/E, the stock looks like a recovery trade rather than a growth premium. This idea lays out an actionable long: entry at $50.59, stop at $45.00, target $68.00 ov…
United Community Banks (UCB) has rebuilt core profitability, generates meaningful free cash flow, and is executing accretive M&A and shareholder returns. At roughly $36.60 today, the stock trades at ~13.5x trailing earnings and 1.2x book with a 2.7% yield. We initiate a Buy with a mid-term (45 trading days) price target of $42.00, a tight stop at $…
Encore Capital (ECPG) offers an asymmetric risk-reward for disciplined buyers. The company is executing a sensible refinancing plan, collections and portfolio purchases remain healthy, and shares trade at a single-digit P/E with a 52-week range that still leaves upside. Take a small, defined long position with a clear stop and a multi-month holding…
Compass Therapeutics announced that data from its randomized Phase 2/3 COMPANION-002 trial evaluating tovecimig combined with paclitaxel in patients with advanced biliary tract cancer will be presented orally at the upcoming ESMO Congress. This presentation highlights clinical progress in their bispecific antibody program targeting DLL4 and VEGF-A …
Homeland Security Secretary Markwayne Mullin told state election officials they could face fines, penalties and even prison time if they do not adopt measures the department has outlined to prevent non-citizen voting and to secure voting machines. The warnings came after President Trump renewed unproven claims about past election fraud and accused …
Immatics N.V. announced it will present three key clinical trial data updates for its PRAME-targeted cell therapies and bispecifics at the ESMO Congress 2026, highlighting progress in multiple solid tumor indications. These presentations underscore the breadth of Immatics' PRAME franchise and support continued development of their immunotherapies a…
Four top Democrats competing to be their party’s U.S. Senate nominee in Maine used a Thursday debate to focus attacks on Republican Senator Susan Collins and President Donald Trump, while largely avoiding intra-party attacks. The candidates embraced a progressive policy slate similar to the withdrawn front-runner’s, debated electability, and highli…
Moelis & Company (MC) just gave investors a clean entry after a sharp sell-off. The advisory firm still prints high ROE, solid free cash flow and a dividend yield that cushions downside. Technical momentum and falling short interest add to the bull case. Here's a pragmatic trade plan with entry, stop and targets across three horizons.
